1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP
    Dismiss Notice

A Single Methamphetamine Administration Rapidly Decreases Vesicular Dopamine Uptake

Provides evidence that psychostimulants rapidly and differentially modify vesicular DA uptake.

  1. Calliope
    THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS ol. 302, No. 2

    JEFFREY M. BROWN, EVAN L. RIDDLE, VER ´ONICA SANDOVAL, RAUL K. WESTON, JAROM E. HANSON, MICHAEL J. CROSBY, YVETTE V. UGARTE, JAMES W. GIBB, GLEN R. HANSON, and ANNETTE E. FLECKENSTEIN

    ABSTRACT
    Recent studies demonstrated that vesicular dopamine (DA) uptake can be rapidly altered in synaptic vesicles purified from the striata of stimulant-treated rats. Specifically, a single ad-ministration of the plasmalemmal DA transporter inhibitor, co-caine, or the DA D2 agonist, quinpirole, increases vesicular DA uptake in vesicles purified from the striata of treated rats. These effects of cocaine are prevented by pretreatment with a D2, but not D1, DA receptor antagonist. The purpose of the present study was to characterize the effect of a mechanistically differ-ent psychostimulant, methamphetamine (METH), on vesicular DA uptake. Results demonstrated that a single administration of this DA-releasing agent rapidly and reversibly decreased vesicular DA uptake. The METH-related decrease in vesicular DA uptake was attenuated by pretreatment with the D2 antag-onist, eticlopride, but not the D1 antagonist, SCH23390 (R-[]-
    7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine). Core body temperature did not contribute to the effects of METH on vesicular DA uptake. Neither quinpirole nor cocaine increased vesicular DA uptake when rats were concurrently treated with METH. These studies provide further evidence that psychostimulants rapidly and differentially modify vesicular DA uptake. In addition, these studies demonstrate a complex role for D2 DA receptors in altering vesicular DA trans-port.